ArticleMolecular cancer therapeutics2021

High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.

Lindy Vernooij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.